Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer's disease treatment-Reference-Cited by-同舟云学术

Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer's disease treatment

Published:2019-12-03 Issue:4 Volume:72 Page:641-651
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Ishima Yu¹²,Mimono Ai³,Tuan Giam Chuang Victor²,Fukuda Tetsuya³,Kusumoto Kohshi¹,Okuhira Keiichiro¹,Suwa Yoshiaki⁴,Watanabe Hiroshi³,Ishida Tatsuhiro¹,Morioka Hiroshi⁴,Maruyama Toru³,Otagiri Masaki⁵⁶

Affiliation:

1. Department of Pharmacokinetics and BiopharmaceuticsInstitute of Biomedical Sciences, Tokushima University Tokushima Japan

2. School of PharmacyMonash University Malaysia, Jalan Lagoon Selatan Subang Jaya Selangor Malaysia

3. Department of BiopharmaceuticsGraduate School of Pharmaceutical Sciences, Kumamoto University, Oe‐honmachi Kumamoto Japan

4. Department of Analytical and Biophysical ChemistryGraduate School of Pharmaceutical Sciences, Kumamoto University Kumamoto Japan

5. Faculty of Pharmaceutical SciencesSojo University, Ikeda Kumamoto Japan

6. DDS Research InstituteSojo University, Ikeda Kumamoto Japan

Funder

Japan Society for the Promotion of Science

Mishima Kaiun Memorial Foundation

Ministry of Education, Culture, Sports, Science and Technology

Publisher